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Oxidized LOL and lipoprotein(a) stimulate renin release of juxtaglo.
merular cells. Atherogenic lipoproteins accumulate in the arterial wall
and may potentially stimulate neighboring cells. In the glomerulus the
vascular pole resembles afferent arteries in close vicinity to the juxtaglo-
merular apparatus. We examined the effects of native and oxidized LDL
and lipoprotein(a) [Lp(a)1 on renin release of juxtaglomerular cells (JG
cells) prepared in primary culture from mouse kidneys. Renin activity of
JG cells was measured in culture supernatants and cells between the 20th
and 40th hour of culturing. Spontaneous renin release into the cell
supernatant was 26 1% of total activity. Control stimulation of JG cells
by melittin or forskolin dose-dependently increased renin release up to 90
2%. Incubation of JG cells with native LDL (50 and 300 jg/ml) or
native Lp(a) (30 Wml) did not alter renin release. Oxidized LDL
increased renin release to 34 1% and 43 1% at 50 and 300 Wml,
while oxidized Lp(a) stimulated renin release to 33 1%, 42 1%, and
71 2% at 1, 10, and 30 Wml, respectively. Coincubation with
superoxide dismutase and catalase, enzymes removing 02 and H202,
completely eliminated oxidized LDL and Lp(a)-stimulated renin release.
In the absence of lipoproteins, renin release was significantly stimulated by
activation of 02 formation by the xanthine/xanthine oxidase reaction.
These data indicate that oxidized LDL and Lp(a) stimulate renin release
in JG cells by a mechanism involving oxygen-derived radicals. Thus,
oxidatively modified atherogenic lipoproteins may contribute to renin-
dependent hypertension in renoparenchymatous kidney disease.
Release of renin into the circulation by juxtaglomerular (JG)
cells is an important physiological contribution of the kidney to
the maintenance of body fluid homeostasis and control of systemic
blood pressure. The regulation of renin release is complex and
includes sensing of renal artery pressure, renal blood flow, tubular
sodium chloride concentration, activity of the sympathetic ner-
vous system (involving a and j3 receptors), as well as inhibitory
and stimulatory effects of a number of humoral factors [reviewed
in 1].
Activation of the renin-angiotensin system is a major factor
responsible for the development of hypertension [2]. A high renin
state in patients with hypertension has also been identified as a
predictor for myocardial infarction [3]. A subset of patients with
hypertension also exhibits high levels of atherogenic plasma
lipoproteins such as low density lipoprotein (LDL) and lipopro-
tein(a) [Lp(a)] [4]. The same association is well known in patients
with coronary heart disease [5]. Therefore, the question deserves
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attention whether plasma lipoproteins, which possess many cell-
stimulating activities [6—8] and are found at increased levels in
various diseases accompanied by the nephrotic syndrome [9],
stimulate renin release. Lipoproteins are present not only in the
circulating blood stream, but they also accumulate in the arterial
wall, where they are likely to undergo oxidative modification [10,
111. Lp(a) deposits—like LDL—have been identified in coronary
vessels [12] and in glomeruli in various forms of renal disease [13].
Thus, these lipoproteins could influence renin release either in
their native form, originating from the blood stream, or after
oxidative modification, originating from subintimal deposits neigh-
boring JG cells. As the afferent arteriole approaches the glomer-
ulus, its smooth muscle cells become modified and epitheloid in
appearance, and they contain numerous densely packed granules
which have been shown to contain renin.
Therefore, the purpose of the present study was to investigate
direct effects of native and oxidized LDL and Lp(a) on renin
release of JG cells. However, atherogenic lipoproteins are potent
modulators of vascular tone [14—16]. Thus, to identify direct
effects, it was important to minimize other interfering influences
on renin release. For example, in a whole kidney preparation,
interfering effects on renin release could be triggered by lipopro-
tein-induced changes of renal blood flow or renal artery pressure.
To circumvent these problems, we chose the isolated JG cell
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preparation in primary culture developed by Kurtz and colleagues
[17]. Furthermore, we considered whether a possible stimulation
of renin release by lipoproteins involves formation of oxygen-
derived radicals. Reactive oxygen species are important mediators
in various clinical renal disease entities [18], and their formation
is stimulated in arteries of hypercholesterolemic animals or after
lipoprotein treatment in vitro [19, 20]. Therefore, we studied the
effect of the superoxide anion producing xanthine/xanthine oxi-
dase reaction on renin release, and of superoxide dismutase and
of the H202 removing enzyme catalase on lipoprotein-stimulated
renin release.
Methods
Reagents
Melittin, acetylcholine, forskolin, dextran sulfate, indometha-
ci superoxide dismutase (SOD), di-methyl-sulfoxide (DMSO),
xanthine, xanthine oxidase, and catalase were obtained from
Sigma (Munich, Germany). Forskolin was dissolved in DMSO and
further diluted in buffer I of the following composition: 130 mM
NaCl, 5 mrvi KC1, 2 ms CaC12, 10 m'i glucose, 20 m sucrose, 10
mM HEPES (Boehringer, Mannheim, Germany). Indomethacin
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was dissolved in ethanol-0.1 M NaHCO3 (1:3) vol/vol. All other
drugs were dissolved in distilled water and also further diluted in
buffer I.
Preparation and oxidation of LDL and Lp(a)
Human LDL was isolated by sequential ultracentrifugation and
stored at 4°C as described recently [15]. An Lp(a) enriched
regeneration fluid was obtained from an LDL-apheresis system
based on heparin induced extracorporeal LDL-precipitation sys-
tem (H.E.L.P.; Braun Melsungen, Melsungen, Germany). The
regenerate fluid was ultracentrifuged first at a density of 1.065
kg/liter, then at 1.120 kg/liter and subjected to density gradient
ultracentrifugation. Finally Lp(a) was purified using Sephadex
G-25M gel chromatography and lysine sepharose 4B chromatog-
raphy and dialyzed against 150 mrvi NaC1, 1 mri EDTA (pH 7.4).
Purity of the Lp(a) preparation was determined by agarose gel
electrophoresis as well as by 4% SDS-PAGE and immunoblotting
with a monoclonal antibody against apo(a) (4F3; Cappel,
Durham, NC, USA). Detection was carried out using the Vect-
astatin ABC antimouse IgG system (Vector Laboratories, Burl-
ingame, CA, USA). Apo(a) isoforms of the donor were larger
than apoB-100 and corresponded to S1/S2 of the Utermann
classification [21]. They were identified using an internal standard
of a defined isoform pool (Immuno, Vienna, Austria). Lp(a) was
oxidized in a similar fashion as LDL as described recently [151.
Briefly, antioxidant-free LDL or Lp(a) (0.3 mg protein/ml) was
incubated with CuSO4 (5 iM) for 24 hours at 23°C. The degree of
oxidation was quantified by two different methods: (i) the increase
in relative mobility on agarose gel, indicating an enhanced nega-
tive charge of oxidized lipoprotein; and (ii) the formation of
thiobarbituric acid-reactive substances (TBARS) [22]. Homo-
geneity of lipoproteins was tested by agarose gel electrophoresis
(lipidophor electrophoresis kits; IMMUNO, Heidelberg, Germa-
ny). The relative mobilities of oxidized LDL and oxidized Lp(a)
on agarose gel electrophoresis as an index for lipoprotein oxida-
tion were 1.4 and 1.6 compared with native LDL and native Lp(a),
respectively. TBARS levels, determined in probes containing 0.3
mg lipoprotein per ml, were 0.2 0.01 M in native LDL, 0.2
0.01 LM in native Lp(a), 3.4 0.8 .LM in oxidized LDL, and 5.2
1 jiM in oxidized Lp(a). Lp(a) was stored at room temperature.
Lipoproteins were freshly prepared every two weeks.
Preparation and primaiy culture of mouse JG cells
Preparation of mouse JG cells was performed according to the
method described by Kurtz et al [23]. After sacrifice of the animals
(6- to 8-week-old mice of either sex, strain C57B16) by cervical
dislocation, the kidneys were removed, decapsulated, and minced
with a razor blade. For a typical preparation, six kidneys were
used. The minced tissue was incubated for 70 minutes at 37°C and
pH 7.4 under continuous stirring in buffer I supplemented with
0.25% trypsin (Sigma) and 0.1% collagenase (Boehringer). Single
cells were obtained by sifting the cell suspension over a 22 jim
mesh. The cells collected after centrifugation at 1,500 X g for 10
minutes were washed with buffer and mixed with 60 m of a 30%
isoosmotic Percoll solution (Pharmacia, Freiburg, Germany) and
distributed into two centrifugation vials. After centrifugation at
27,000 X g in a SS34 Sorvall rotor for 25 minutes, four apparent
bands were obtained. As shown by Kurtz et a! in a previous
publication, band III cells (density 1.075 g/mL) had a twofold
specific renin activity as compared with band II, and a 64-fold
activity as compared with band I [23]. For primary culture of JG
cells, the cells of the band III with the highest specific renin
activity were used. These cells were cleaned from Percoll by
washing with buffer and finally suspended in culture medium
(RPMI 1640, Gibco BRL, Eggenstein, Germany). The culture
medium was supplemented with 100 U/mi penicillin, 0.66 U/ml
insulin, 100 jig/mI streptomycin, and 2% dialyzed fetal bovine
serum (Gibco BRL). Three milliliters of culture medium contain-
ing approximately 3 >< 106 cells were distributed in 50 jil portions
into 96-well plates (Falcon, NJ, USA) and incubated at 37°C in a
cell incubator (Heraeus, Stuttgart, Germany) containing 5% CO2
in a humidified atmosphere. For renin immunostaining, the cells
were seeded onto glass cover slips coated with 0.1% collagen
(Seromed, Berlin, Germany) and placed in 24-well plates (Fal-
con).
Renin immunostaining
Immunoperoxidase staining of renin containing cells in culture
was carried out as described recently by Della Bruna et al [24]. On
the second day after seeding the culture medium was removed,
and the cells were washed twice with Tris-buffered saline (TBS;
150 mM NaCJ, 50 ms'i Tris, pH 7.2). Then the cells were fixed with
2% formaldehyde (Merck, Darmstadt, Germany) in TBS supple-
mented with 5 mrvi MgC12 (Merck) for 30 minutes. Afterwards the
cells were washed three times for five minutes with TBS. To block
endogenous peroxidase activity, the cells were incubated with
0.5% H2O2 (Fischer, Saarbrücken, Germany) in methanol for 30
minutes, followed by rehydration in TBS for 30 minutes. Then the
cells were incubated in blocking buffer [TBS supplemented with
1% bovine serum albumin (Sigma) and 10% fetal calf serum
(Gibco)] for one hour. Subsequently, the cells were incubated
with rat antiserum against mouse renin (final dilution 1:200; gift of
Prof. A. Kurtz, Regensburg, Germany) at 4°C overnight. After
this incubation period, the cells were washed five times for five
minutes with TBS at room temperature. Then goat antirat anti-
body (Dianova, Hamburg, Germany; final dilution 1:200) was
added for two hours at room temperature. Nonbound antibody
was removed by washing five times for five minutes with TBS.
Bound antibody was reacted with rabbit antigoat IgG (Dianova,
Hamburg, Germany; final dilution 1:500) linked to peroxidase
(Bioyeda, Basel, Switzerland). After washing five times for five
minutes, peroxidase activity was demonstrated by incubation with
diaminobenzidine (DAB, Sigma) solution (0.6 mg DAB/mI Tris
buffer, pH 7.6). Controls were performed using normal rabbit
serum instead of antirenin serum. Immunostaining was visualized
by light microscopy (Leitz, Wetzlar, Germany).
Experimental design
JG cells were stimulated with melittin (0.1 to 10 jiM), forskolin
(1 to 100 jiM), native LDL (50 and 300 jig/mi), native Lp(a) (30
jig/mi), oxidized LDL (50 and 300 jig/ml), and oxidized Lp(a)
(1, 10, and 30 jig/ml) between the 20th and 40th hour of culturing
after their plating in 96 well plates. In three additional experi-
ments, the influence of oxidized LDL (300 jig/ml) and oxidized
Lp(a) (30 jig/mI) on renin release was determined after only two
hours of incubation. At the end of the incubation period, the cells
were washed, and fresh buffer was added followed by addition of
the substances to be tested (or their respective solvents as
controls). At the end of the stimulation periods the supernatants
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and the cells were harvested. The influence of superoxide dis-
mutase (SOD) and catalase on basal and lipoprotein-stimulated
renin release was determined by coincubation of JG cells with
either SOD (0.1 ELM) and catalase (100 U/mi) alone or in
combination, in the absence or presence of oxidized LDL and
Lp(a). The effect of the 02 generating xanthine/xanthine oxidase
reaction on renin release in the absence of iipoproteins was tested
by coincubation of JG cells with xanthine (400 nM) and xanthine
oxidase (0.002 or 0.02 U/mi).
Renin activity was determined both in the supernatants and in
the cells. In each experiment, four separate wells treated identi-
cally with the lipoproteins, melittin or forskolin were tested for
viability at the end of the incubation period by exclusion of tiypan
blue (Sigma) using a blinded protocol. In three additional exper-
iments, release of the cytoplasmic marker lactate dehydrogenase
(LDH) into the cell supernatant of unstimulated JG cells and cells
treated with the various stimulants was determined spectropho-
tometrically using a commercially available reagent kit (Merck).
Intracellular LDH content was measured after harvesting the cells
as described below. For each measurement, the supernatants and
the intracellular content were pooled from five wells. LDH activity
is expressed in U/liter.
Determination of renin activity
Renin activity in terms of its ability to generate angiotensin I
(Ang I) from angiotensinogen was detected by radioimmunoassay
using a commerially available kit (Sorin, Saluggia, Italy). Plasma
of bilaterally nephrectomized rats rich in angiotensinogen served
as substrate for active renin [25]. For quantitative comparison of
data, renin release rates were calculated as the percentage of
extracellular renin activity related to the total (intracellular +
extracellular) renin activity. Extracellular renin activity was deter-
mined in the cell supernatants after collection from the 96 well
plates at the end of the incubation periods. To determine the
intracellular content of renin activity, the supernatant culture
medium was thoroughly removed from the culture plates at the
end of the incubation periods. In order to lyse the JG cells, 100 jtl
of phosphate buffered saline supplemented with 0.1% Triton
X-100 and 2% fetal calf serum (Gibco BRL) was added to each
dish, followed by a 15 mm incubation period at 37°C. After
shaking the plates for 30 mm at room temperature, the solutions
were removed, centrifuged at 3,500 X g for 20 minutes, and the
supernatants were collected and stored at —20°C for further
processing.
To ensure that the fractional renin release was independent of
total renin release, we performed control experiments and seeded
the cells at different densities (50,000 to 400,000 cells/well) and
measured spontaneous and forskolin-stimulated fractional renin
release. These experiments revealed that basal and stimulated
fractional renin release are independent of total renin activity.
Actual renin activity in the cell supernatants of unstimulated cells
varied between 162 11 ng Ang I per well at a density of 50,000
cells/well and 1266 107 ng Ang I per well at a density of 400,000
cells/well. Renin activity in the supernatants of forskolin-stimu-
lated cells varied between 248 29 ng Ang I per well at a density
of 50,000 cells/well and 1805 121 ng Ang I per well at a density
of 400,000 cells/well. This corresponded to 7.45 0.9 g Aug
I/hr/100 tg cellular protein under basal, and to 12.41 0.32 jg
Ang I/hr/100 ig cellular protein under forskolin-stimulated con-
ditions.
Statistics
Data in Figures 2 to 10 are presented as means SE of N
experiments, with each experiment representing the mean of five
replicate culture wells. Statistical significance of differences in
Figures 2 to 10 was calculated using analysis of variance. For
multiple comparison of data, Bonferroni's correction was applied.
Dose effects in the plots in Figure 1 were determined using one
way analysis of variance. Differences were considered significant
at an error probability of P < 0.05.
Results
Renin immunostaining and viability of JG cells
We assessed the distribution of renin containing cells on the
second day of primary culture utilizing peroxidase-linked antibody
staining directed against mouse renin. Almost all cells stained
positively for renin when the specific antiserum against mouse
renin was used. When normal rabbit serum instead of the specific
antiserum was used as control, no cells stained positively (not
shown). At the end of the incubation periods, all cell preparations
completely excluded Trypan blue except those treated with 30
ig/ml oxidized Lp(a). In those preparations, about 15% of the
cells showed an uptake of the stain, which was prevented by
additional treatment with catalase. In three additional experi-
ments, control cells released 7 2 U LDH per five wells into the
supernatant, corresponding to 23 3% of total cellular LDH
content. Treatment of the cell preparations with the various
stimulants slightly, but not significantly increased LDH release.
Only treatment with oxidized Lp(a) significantly increased LDH
release to 11 3 U LDH per five wells, corresponding to 32 3%
of total cellular LDH content. This increase was also prevented by
additional treatment of the cells with catalase.
Renin release
Basal and melittin- or forskolin-stimulated renin release. Renin
release of JG cells, determined as the percentage of extracellular
renin activity compared to the total renin activity after 20 hours of
incubation, was 26 1% of total renin activity under basal,
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Fig. 1. Renin release of cultured juxtaglomerular cells calculated as a
percentage of exzracellular renin activity compared to total renin activity after
20 hours of incubation with buffer (basal) or different concentrations of
melittin (•) or forskolin (0). Data are means SE of four independent
experiments, each representing 5 replicate wells.
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Fig. 2. Bar graph showing the effect of native LDL (50 and 300 igIml) and
of melittin (1 imol/liter) on renin release of cultured juxtaglomerular cells.
Renin release was calculated as a percentage of extracellular renin activity
compared to total renin activity after 20 hours of incubation with buffer
(basal, ), native LDL (U), or melittin (). While melittin stimulated
renin release significantly, native LDL had no effect on renin release.
*Statistically significant difference between basal renin release and stim-
ulated renin release at P < 0.05. Data are means SE of three
independent experiments, each representing 5 replicate wells.
unstimulated conditions. Stimulation of the cells with melittin (0.1
to 10 .LM) or forskolin (1 to 100 j.M) concentration-dependently
increased the renin release (Fig. 1).
Effects of native and oxidized LDL on renin release. Stimulation
of JG cells for 20 hours with native LDL (50 and 300 ig/m1) had
no effect on renin release (Fig. 2). However, when the cells were
stimulated for 20 hours with oxidized LDL in equivalent concen-
tration, renin release was increased dose-dependently (Fig. 3).
Incubation of the JG cells with oxidized LDL (300 tg/ml) for only
two hours had no effect on renin release (data not shown).
Effects of native and oxidized Lp(a) on renin release. Similar to
native LDL, native Lp(a) (30 j.tg/ml, 20 hours incubation) did not
stimulate renin release (Fig. 4). Oxidized Lp(a), however, dose-
dependently increased renin release of cultured JG cells after 20
hours of incubation (Fig. 5). In this respect, oxidized Lp(a) was far
more potent compared to oxidized LDL; at 10 .tWml, thus at a
30-fold lower concentration it elicited the same stimulatory effect
as 300 ig/ml of oxidized LDL, and, at 30 Lg/ml, it was as effective
as 1 M melittin. After two hours of incubation, oxidized Lp(a)
(30 g/ml) stimulated renin release from 23 1% under basal
conditions to 53 2% (N = 3 experiments).
Influence of dextran sulfate on renin release stimulated by oxidized
Lp(a). To determine whether the stimulatory effect of oxidized
Lp(a) on renin release involved activation of the scavenger
receptor, we performed a series of experiments with the scavenger
receptor antagonist dextran sulfate. Coincubation of JG cells with
dextran sulfate (10 jxg/ml), however, had no inhibitory effect on
the stimulation of renin release by oxidized Lp(a) (Fig. 6).
Effect of indomethacin on renin release stimulated by oxidized
Lp(a). To study whether oxidized Lp(a) stimulates formation of
prostaglandins, which in turn could stimulate renin release, we
exposed the JG cells simultaneously to the cyclooxygenase inhib-
itor indomethacin (50 .LM) during the stimulation period with
Fig. 3. Bar graph showing the effect of oxidized LDL (50 and 300 jig/mI)
and of melittin (1 j.vnol/l) on renin release of cultured juxtaglomerular cells.
Renin release was calculated as a percentage of extracellular renin activity
compared to total renin activity after 20 hours of incubation with buffer
(basal, Cl), oxidized LDL (U), or melittin (). Oxidized LDL significantly,
dose-dependently stimulated renin release. * Statistically significant differ-
ence between basal renin release and stimulated renin release at P < 0.05.
Data are means SE of four independent experiments, each representing
5 replicate wells.
oxidized Lp(a). As shown in Figure 7, inhibition of cyclooxygenase
had no influence on the stimulatory effect of oxidized Lp(a),
making prostaglandins as mediator unlikely.
Influence of superoxide dismutase and catalase on renin release
stimulated by oxidized Lp(a). Oxidized Lp(a)-induced stimulation
of renin release might involve formation of oxygen-derived radi-
cals. We therefore studied the influence of superoxide dismutase
and of the H202 removing enzyme catalase on basal and on
oxidized Lp(a)-stimulated renin release. Superoxide dismutase
and catalase alone or in combination had no influence on basal
renin release. However, renin release stimulated by oxidized
Lp(a) was further enhanced in the presence of superoxide dis-
mutase. Catalase prevented stimulation of renin release by oxi-
dized Lp(a), both in the presence and in the absence of super-
oxide dismutase (Fig. 8).
Influence of superoxide dismutase and catalase on renin release
stimulated by oxidized LDL. Likewise, we studied the influence of
SOD and of catalase on basal and on oxidized LDL-stimulated
renin release. In the presence of superoxide dismutase renin
release stimulation by oxidized LDL was partly inhibited. Addi-
tion of catalase completely prevented oxidized LDL-stimulated
renin release (Fig. 9).
Effect of the xanthine/xanthine oxidase reaction on renin release.
To study whether generation of 02 in the absence of lipopro-
teins modulates renin release, we stimulated JG cells with xan-
thine and xanthine oxidase. xanthine (400 nM) alone or 0.002 U/ml
xanthine oxidase alone had no influence on renin release. At 0.02
U/mi, xanthine oxidase significantly stimulated renin release. In
the presence of xanthine, stimulation of renin release by xanthine
oxidase was greatly enhanced (Fig. 10).
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Fig. 4. Bar graph showing the effect of native lipoprotein(a) [native Lp(a),
30 pg/mI] and of melittin (1 .unol/liter) on renin release of culturedjuxtaglomerular cells. Renin release was calculated as a percentage of
extracellular renin activity compared to total renin activity after 20 hours
of incubation with buffer (basal, LI), native Lp(a) (U), or melittin ().
While melittin stimulated renin release significantly, native Lp(a) had no
effect on renin release. *statistically significant difference between basal
renin release and stimulated renin release at P < 0.05. Data are means
SEof three independent experiments, each representing 5 replicate wells.
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Fig. 5. Bar graph showing the effect of oxidized lipoprotein(a) [oxidized
Lp(a), 1, 10, and 30 pg/mI] and of melittin (1 pinol/liter) on renin release of
cultured juxtaglomerular cells. Renin release was calculated as a percentage
of extracellular renin activity compared to total renin activity after 20
hours of incubation with buffer (basal, LI), oxidized Lp(a) (U), or melittin
(n). Oxidized Lp(a) significantly, dose-dependently stimulated renin
release. *Statistically significant difference between basal renin release
and stimulated renin release at P < 0.05. Data are means s of four
independent experiments, each representing 5 replicate wells.
Discussion
This study was undertaken in order to determine whether
atherogenic lipoproteins modulate renin release of isolated JG
10 pg/mI +dex 30 pg/mI +dex
Fig. 6. Bar graph showing the influence of the scavenger-receptor antagonist
dextran sulfate (10 pg/mI) on renin release stimulated by oxidized lipopro-
tein(a) in cultured juxtaglomerular cells. Renin release was calculated as a
percentage of extracellular renin activity compared to total renin activity
after 20 hours of incubation with oxidized Lp(a) (10 and 30 g/ml, U), or
oxidized Lp(a) plus dextran sulfate (). Dextran sulfate had no influence
on Lp(a)-stimulated renin release. Data are means SE of three
independent experiments, each representing 5 replicate wells.
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Fig. 7. Bar graph showing the influence of the cyclooxygenase inhibitor
indomethacin (50 pM) on renin release stimulated by oxidized lipoprotein(a)
in cultured juxtaglomerular cells. Renin release was calculated as a percent-
age of extracellular renin activity compared to total renin activity after 20
hours of incubation with oxidized Lp(a) (1, 10 and 30 pg/mI, U), or
oxidized Lp(a) plus indomethacin (). Indomethacin had no influence on
Lp(a)-stimulated renin release. Data are means SE of three independent
experiments, each representing 5 replicate wells.
cells in primary culture. The salient findings were that the native
forms of LDL and Lp(a) were without influence on renin release.
However, LDL and Lp(a) were potent stimulants of renin release
after oxidative modification. In this respect, oxidized Lp(a) was
about 30-fold more potent than oxidized LDL. The stimulation of
renin release was completely inhibited by the H202 removing
enzyme catalase. This inhibition provides evidence for a role of
oxygen-derived radicals in the stimulatory action of oxidized
lipoproteins on renin release.
1 pg/mI +indo 10 pg/mI +ndo 30 pg/mI +irido
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Fig. 8. Bar graph showing the influence of superoxide dismutase (SOD, 0.1
pu) and of catalase (cat, 100 U/ml) on basal (L) and on oxidized
lipoprotein(a)-stimulated (30 pg/mI, •) renin release in cultured juxtaglo-
merular cells. Renin release was calculated as a percentage of extracellular
renin activity compared to total renin activity after 20 hours of incubation
with the respective substances. SOD and catalase had no influence on
basal renin release, while stimulation of renin release by oxidized Lp(a)
was further enhanced in the presence of SOD, and completely prevented
by catalase. Statistically significant difference between basal renin release
and stimulated renin release at P < 0.05. Data are means SE of four
independent experiments, each representing 5 replicate wells.
The central role of the renin-angiotensin-aldosterone system in
the regulation of arterial blood pressure and electrolyte ho-
meostasis is well known. Activation of this system is an important
cause or predictor for cardiovascular diseases, such as the devel-
opment of hypertension [2, 263 or myocardial infarction in pa-
tients with hypertension [3, 273. Because occurrence of cardiovas-
cular disease is positively correlated with increased levels of LDL
and Lp(a) [4, 5], we were interested to know whether these
lipoproteins, which possess many cell-stimulating activities [6—8],
would activate renin release. We studied the effects of native and
of oxidized lipoproteins, because JG cells could be influenced by
circulating, presumably native lipoproteins, as well as by lipopro-
teins accumulating locally in the vessel wall and in the glomeruli
[13, 28], where they are likely to undergo oxidative modification
[29]. The model of isolated JG cells in culture was chosen because
it demonstrates several advantages for studying this issue. First,
preparation of cells reveals almost exclusively renin containing
cells, as demonstrated by immunostaining against mouse renin.
Second, cells can be characterized by their dose dependent
response to the well established activators of renin release,
melittin and forskolin. And third, the model enables studies of the
direct effects of the lipoproteins on renin release. This is partic-
ularly important, since especially oxidized lipoproteins induce
impairment of endothelial function and changes in vascular tone
[14, 16], which in a whole kidney preparation could influence
renin release indirectly, for example, via activation of the renal
baroreceptor mechanism [30].
Native LDL and native Lp(a) did not stimulate renin release.
However, when these lipoproteins were oxidatively modified,
renin release was strongly stimulated. Oxidized LDL and Lp(a)
bind to the so-called scavenger receptor [31, 323, which, for
example is expressed by smooth muscle cells. Because JG cells are
Fig. 9. Bar graph showing the influence of superoxide dismutase (SOD, 0.1
pus) and of catalase (cat, 100 U/mI) on basal (LI) and on oxidized
LDL-stimulated (300 jig/mI, •) renin release in cultured juxtaglomerular
cells. Renin release was calculated as a percentage of extracellular renin
activity compared to total renin activity after 20 hours of incubation with
the respective substances. SOD and catalase had no influence on basal
renin release, while stimulation of renin release by oxidized LDL was
partly inhibited in the presence of SOD, strongly inhibited in the presence
of catalase, and completely prevented by catalase + SOD. *Statistically
significant difference between basal renin release and stimulated renin
release at P < 0.05. Data are means SE of four independent experi-
ments, each representing 5 replicate wells.
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modified vascular smooth muscle cells [33], a series of experi-
ments was performed with oxidized Lp(a) in the presence of the
scavenger receptor dextran sulfate [343 to determine if the stim-
ulation is mediated by the scavenger receptor pathway. Dextran
sulfate, however, had no influence on the stimulation of renin
release, making involvement of the scavenger receptor stimulation
unlikely. Prostaglandins, especially prostacyclin, are strong stim-
ulants for cyclic adenosine 3',5'-monophosphate-mediated renin
release [35, 36]. Oxidized lipoproteins have been shown to
stimulate prostacyclin production in human endothelial cells [37].
We therefore studied the effect of the cyclooxygenase inhibitor
indomethacin on oxidized Lp(a)-induced stimulation of renin
release. However, indomethacin was found to be without effect on
the stimulation.
In studies investigating vascular reactivity in arteries treated
with lipoproteins or obtained from hypercholesterolemic animals,
it has been suggested that defective vasomotor responses were in
part elicited by formation of reactive oxygen species, because the
effects could be blocked by superoxide dismutase [19] or catalase
[203, which prevent accumulation of 02 and H202, respectively.
We therefore investigated whether superoxide dismutase or cata-
lase influence oxidized LDL- and Lp(a)-stimulated renin release.
In the presence of superoxide dismutase, oxidized LDL-stimu-
lated renin release was slightly inhibited, whereas renin release
stimulated by oxidized Lp(a) was slightly enhanced. The presence
of catalase, however, eliminated renin release stimulated by both
oxidized LDL and Lp(a). Control experiments revealed that
catalase alone had no influence on basal or melittin-stimulated
renin release. This observation provides indirect evidence for the
involvement of reactive oxygen species in the stimulation of renin
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Fig. 10. Bar graph showing the influence of the superoxide anion generating
xanthine/xanthine oxidase reaction on basal renin release (open bar) in
cultured juxtaglomerular cells. Renin release was calculated as a percentage
of extracellular renin activity compared to total renin activity after 20
hours of incubation with the respective substances. Xanthine (400 nM)
alone () and 0.002 U/ml xanthine oxidase alone () had no influence on
basal renin release, while 0.02 U/mI xanthine oxidase (right striped bar)
significantly stimulated renin release. In the presence of xanthine, stimu-
lation of renin release by xanthine oxidase was greatly enhanced (U).
*statistically significant difference between basal renin release and stim-
ulated renin release at P < 0.05. Data are means SE of three
independent experiments, each representing 5 replicate wells.
release by oxidized lipoproteins. An increased 02 production
has been found in arteries of hypercholesterolemic rabbits [38],
and lipid peroxide containing material obtained from human
atherosclerotic lesions stimulated hydroxyl-radical formation in
liver cells [39]. Thus, one may speculate that oxidized LDL and
Lp(a) stimulate JG cells to produce 02 and H202, the latter
being the substrate for hydroxyl-radical formation, which is inhib-
ited by catalase [40]. The mechanism by which oxygen radicals
could stimulate renin release remains to be determined. A likely
explanation is that they attack the cell membrane of JG cells,
leading to release of renin stored in intracellular granules. The
relatively high release of LDH from cells treated with oxidized
lipoproteins could also be explained by such an impairment of cell
membrane integrity. The cause for the equivocal effect of super-
oxide dismutase may be explained by the sometimes deleterious
effects of too much superoxide dismutase activity in relation to
H202-removing enzymes; in the absence of catalase, superoxide
dismutase sometimes favors formation of the biologically most
active hydroxyl-radical [18, 40].
To further evaluate this potential mechanism, another series of
experiments was performed using the 02 producing xanthine/
xanthine oxidase reaction to determine whether reactive oxygen
species in the absence of lipoproteins would stimulate renin
release. Indeed, renin release was potently stimulated by coincu-
bation of JG cells with xanthine/xanthine oxidase, providing
further evidence for a stimulatosy role of oxygen derived radicals
on renin release.
Oxidized Lp(a) was about 30-fold more potent than oxidized
LDL. The reason for this difference is not clear. One might
assume that the state of oxidation of the lipoproteins determines
their stimulatory efficacy, and that Lp(a) more readily undergoes
oxidative modification, resulting in a higher concentration of
oxidized lipids. Indeed, Naruszewicz, Selinger and Davignon [411
found that Lp(a) of an individual donor had higher susceptibility
to oxidation than LDL, probably due to a higher content of
intrinsic antioxidants within the LDL particle. Sattler et al [42],
however, observed a retarded Cu k-mediated oxidation of Lp(a)
in comparison to LDL, a finding which these authors attributed to
a higher content of N-acetylneuraminic acid within Lp(a). A
possible explanation for these differences is the variability in the
content of lipoprotein-associated antioxidants among the individ-
ual donors. In our preparation, Lp(a) was oxidized in a similar
fashion as LDL. This procedure resulted in a somewhat higher
content of TBARS in oxidized Lp(a), compared to oxidized LDL.
However, TBARS reflect only a small portion of primary and
secondary lipid peroxidation products [22], so that caution is
required in the interpretation of data on the extent of oxidation.
Thus, the reason for the significantly higher potency of oxidized
Lp(a) remains to be determined.
Clinical outlook. The pathophysiological interpretation of our
data remains speculative. Our findings raise the question whether
lipoprotein-induced stimulation of renin release contributes to the
pathophysiology of hypertension and coronary heart disease in a
subset of patients with hyperlipidemia. However, to our knowl-
edge, to date no study has focused on a relationship between
plasma renin activity and the presence of native and/or oxidized
lipoproteins in vivo, and there are at present no reported data on
an increased plasma renin activity in hypercholesterolemia and
atherosclerosis. The observation that native lipoproteins did not
stimulate renin release argues against an influence of circulating
LDL or Lp(a) on renin release in vivo. There is, however, indirect
evidence for the presence of oxidized LDL in the afferent
arteriole of cholesterol fed rabbits [43], and oxidized lipoproteins
are considered to play a role in the development of glomerular
scarring [44—46], a condition where concomitant activation of
increased renin release is likely. It is thus tempting to speculate that
oxidized lipoproteins accumulate in the vicinity of JG cells close
enough to exert their stimulatoiy action on renin release. This
stimulation might contribute to renin-dependent hypertension and
cardiovascular disease in renoparenchymatous kidney disease.
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